Atlas Trials

A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension

Clinical trial NCT02206165 · UNKNOWN

Trial details

NCT number
NCT02206165
Sponsor
Chong Kun Dang Pharmaceutical
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Essential Hypertension
Start date
2014-03-01
Primary completion
2015-04-01
Enrollment
456

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.